Angiographic Evidence of Response to Trametinib Therapy for a Spinal Cord Arteriovenous Malformation-Reference-Cited by-同舟云学术

Angiographic Evidence of Response to Trametinib Therapy for a Spinal Cord Arteriovenous Malformation

Published:2021-07-01 Issue:3 Volume:2 Page:e018
ISSN:2690-2702
Container-title:Journal of Vascular Anomalies
language:en
Short-container-title:

Author:

Cooke Daniel L.,Frieden Ilona J.,Shimano Kristin A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference8 articles.

1. Somatic activating KRAS mutations in arteriovenous malformations of the brain.;Nikolaev;N Engl J Med,2018

2. Somatic gain of KRAS function in the endothelium is sufficient to cause vascular malformations that require MEK but not PI3K signaling.;Fish;Circ Res,2020

3. Monitoring arteriovenous malformation response to genotype-targeted therapy.;Edwards;Pediatrics,2020

4. Genotype-guided medical treatment of an arteriovenous malformation in a child.;Lekwuttikarn;JAMA Dermatol,2019

5. Proof-of-concept single-arm trial of bevacizumab therapy for brain arteriovenous malformation.;Muster;BMJ Neurology Open,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates in Genetic Testing for Head and Neck Vascular Anomalies;Oral and Maxillofacial Surgery Clinics of North America;2024-02

2. Clarifying the clinical landscape of pediatric spinal arteriovenous shunts: an institutional experience and individual patient-data meta-analysis;Journal of NeuroInterventional Surgery;2023-03-15

3. Vascular malformations: An overview of their molecular pathways, detection of mutational profiles and subsequent targets for drug therapy;Frontiers in Neurology;2023-02-10

4. A human model of arteriovenous malformation (AVM)-on-a-chip reproduces key disease hallmarks and enables drug testing in perfused human vessel networks;Biomaterials;2022-09

5. Development and characterization of a human model of arteriovenous malformation (AVM)-on-a-chip;2022-01-22